Literature DB >> 25504993

HFE gene variants and iron-induced oxygen radical generation in idiopathic pulmonary fibrosis.

Federica Sangiuolo1, Ermanno Puxeddu1, Gabriella Pezzuto2, Francesco Cavalli3, Giuliana Longo4, Alessia Comandini2, Donato Di Pierro5, Marco Pallante4, Gianluigi Sergiacomi6, Giovanni Simonetti6, Maurizio Zompatori7, Augusto Orlandi8, Andrea Magrini4, Massimo Amicosante4, Francesca Mariani9, Monica Losi2, Daniela Fraboni10, Alberto Bisetti11, Cesare Saltini12.   

Abstract

In idiopathic pulmonary fibrosis (IPF), lung accumulation of excessive extracellular iron and macrophage haemosiderin may suggest disordered iron homeostasis leading to recurring microscopic injury and fibrosing damage. The current study population comprised 89 consistent IPF patients and 107 controls. 54 patients and 11 controls underwent bronchoalveolar lavage (BAL). Haemosiderin was assessed by Perls' stain, BAL fluid malondialdehyde (MDA) by high-performance liquid chromatography, BAL cell iron-dependent oxygen radical generation by fluorimetry and the frequency of hereditary haemochromatosis HFE gene variants by reverse dot blot hybridisation. Macrophage haemosiderin, BAL fluid MDA and BAL cell unstimulated iron-dependent oxygen radical generation were all significantly increased above controls (p<0.05). The frequency of C282Y, S65C and H63D HFE allelic variants was markedly higher in IPF compared with controls (40.4% versus 22.4%, OR 2.35, p=0.008) and was associated with higher iron-dependent oxygen radical generation (HFE variant 107.4±56.0, HFE wild type (wt) 59.4±36.4 and controls 16.7±11.8 fluorescence units per 10(5) BAL cells; p=0.028 HFE variant versus HFE wt, p=0.006 HFE wt versus controls). The data suggest iron dysregulation associated with HFE allelic variants may play an important role in increasing susceptibility to environmental exposures, leading to recurring injury and fibrosis in IPF.
Copyright ©ERS 2015.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25504993     DOI: 10.1183/09031936.00104814

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  12 in total

Review 1.  Oxidant/Antioxidant Disequilibrium in Idiopathic Pulmonary Fibrosis Pathogenesis.

Authors:  Paolo Cameli; Alfonso Carleo; Laura Bergantini; Claudia Landi; Antje Prasse; Elena Bargagli
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

2.  Lung Iron Overload Does Not Exacerbate the Fibrotic Response to Bleomycin in a Mouse Model of Pulmonary Fibrosis.

Authors:  Vida Zhang; Elizabeta Nemeth; Airie Kim
Journal:  Am J Respir Cell Mol Biol       Date:  2020-11       Impact factor: 6.914

Review 3.  Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.

Authors:  Claire Healy; Natalia Munoz-Wolf; Janné Strydom; Lynne Faherty; Niamh C Williams; Sarah Kenny; Seamas C Donnelly; Suzanne M Cloonan
Journal:  Respir Res       Date:  2021-04-29

4.  Hemochromatosis (HFE) Gene Variants Are Associated with Increased Mitochondrial DNA Levels During HIV-1 Infection and Antiretroviral Therapy.

Authors:  Asha R Kallianpur; Mariana Gerschenson; Todd Hulgan; Harpreet Kaur; David B Clifford; David W Haas; Deborah G Murdock; Justin C McArthur; David C Samuels; David M Simpson
Journal:  AIDS Res Hum Retroviruses       Date:  2018-08-22       Impact factor: 2.205

5.  Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.

Authors:  Yusuke Kurita; Jun Araya; Shunsuke Minagawa; Hiromichi Hara; Akihiro Ichikawa; Nayuta Saito; Tsukasa Kadota; Kazuya Tsubouchi; Nahoko Sato; Masahiro Yoshida; Kenji Kobayashi; Saburo Ito; Yu Fujita; Hirofumi Utsumi; Haruhiko Yanagisawa; Mitsuo Hashimoto; Hiroshi Wakui; Yutaka Yoshii; Takeo Ishikawa; Takanori Numata; Yumi Kaneko; Hisatoshi Asano; Makoto Yamashita; Makoto Odaka; Toshiaki Morikawa; Katsutoshi Nakayama; Kazuyoshi Kuwano
Journal:  Respir Res       Date:  2017-06-02

6.  Ironing Out the Roles of Macrophages in Idiopathic Pulmonary Fibrosis.

Authors:  David N O'Dwyer; Bethany B Moore
Journal:  Am J Respir Crit Care Med       Date:  2019-07-15       Impact factor: 21.405

7.  CD71- Alveolar Macrophages in Idiopathic Pulmonary Fibrosis: A Look beyond the Borders of the Disease.

Authors:  Ermanno Puxeddu; Daniela Fraboni; Giuseppe Cillis; Francesco Cavalli; Francesco Buccisano; Paola Rogliani
Journal:  Am J Respir Crit Care Med       Date:  2019-12-01       Impact factor: 21.405

8.  Bronchoalveolar lavage (BAL) cells in idiopathic pulmonary fibrosis express a complex pro-inflammatory, pro-repair, angiogenic activation pattern, likely associated with macrophage iron accumulation.

Authors:  Jungnam Lee; Ivan Arisi; Ermanno Puxeddu; Lazarus K Mramba; Massimo Amicosante; Carmen M Swaisgood; Marco Pallante; Mark L Brantly; C Magnus Sköld; Cesare Saltini
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

9.  The Transferrin Receptor CD71 Delineates Functionally Distinct Airway Macrophage Subsets during Idiopathic Pulmonary Fibrosis.

Authors:  Sarah J Allden; Patricia P Ogger; Poonam Ghai; Peter McErlean; Richard Hewitt; Richard Toshner; Simone A Walker; Peter Saunders; Shaun Kingston; Philip L Molyneaux; Toby M Maher; Clare M Lloyd; Adam J Byrne
Journal:  Am J Respir Crit Care Med       Date:  2019-07-15       Impact factor: 21.405

Review 10.  Metabolic Dysregulation in Idiopathic Pulmonary Fibrosis.

Authors:  Elena Bargagli; Rosa Metella Refini; Miriana d'Alessandro; Laura Bergantini; Paolo Cameli; Lorenza Vantaggiato; Luca Bini; Claudia Landi
Journal:  Int J Mol Sci       Date:  2020-08-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.